Alamar Biosciences Establishes European Headquarters and Distribution Center in Milan, Italy USA - English USA - English
The Californer/10286950

FREMONT, Calif., July 30, 2024 ~ Milan, Italy - Alamar Biosciences, a leading company in precision proteomics for early disease detection, has announced the opening of its European headquarters and distribution center in Milan. This strategic expansion is a significant milestone in the company's mission to advance global scientific research through high-sensitivity biomarker solutions.

The new European headquarters will serve as the central hub for Alamar Biosciences' operations across Europe, providing innovative products and exceptional customer service to its growing base of European clients. The distribution center in Milan will ensure efficient and timely delivery of Alamar's comprehensive range of proteomics products, reinforcing the company's dedication to meeting the evolving needs of the global research community.

"We are thrilled to announce the opening of our European headquarters and distribution center in Milan," said Yuling Luo, Ph.D., Chairman, Founder and CEO of Alamar. "This strategic expansion reflects our ongoing commitment to supporting the scientific community across Europe. Milan's dynamic environment and strategic location will allow us to better serve our customers and accelerate the delivery of our innovative solutions."

More on The Californer

• Poncho Tha Popstar: The West's Next King
• Physician-Turned-Patient Launches Advocacy Campaign to Spotlight Disability Insurance Barriers
• Celebrity Chef Nicole Andrea Guzman Releases Her First Childrens Book
• Thorn Ridge® Creates a World of Legends & Lore
• Screenwriting Cruise Adds Howard Suber, Ph.D., to Inaugural 7-Day Screenwriting Lab at Sea

One of these innovative solutions is Alamar's ARGO™ HT System, a fully automated, high-throughput precision proteomics platform that can be operated with just one push of a button. The system allows for quick and accurate analysis of biomarkers, aiding in early disease detection. Additionally, Alamar's NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.

The establishment of the European headquarters will enable Alamar Biosciences to offer localized support, faster response times, and personalized services to its European customers. This enhanced customer service is crucial for the company's global success.

Furthermore, the new distribution center will streamline logistics and ensure that Alamar's products reach customers across Europe more swiftly and reliably. This improvement in distribution efficiency highlights the company's commitment to growth and innovation in the biotechnology sector, as well as its dedication to improving global healthcare outcomes.

More on The Californer

• Twice the Laughs: Comedy Star Don Barnhart Rotates Residency at Both Delirious Comedy Club Locations in Las Vegas
• Voices for Humanity Ignites a Revolution for Learning with Eva Rehorova
• Omnigarde AI-Powered Face Recognition Achieves Top Global Rankings in Prestigious NIST Evaluation
• Petitioner Urges White House to Issue Executive Order on Divorce Fairness
• Car Wash Deal in Downey CA Prices Starting from $8

Milan, known for its robust infrastructure and central location, offers an ideal location for Alamar Biosciences to strengthen its presence in Europe. "Supporting our European research clients in a timely and efficient manner is essential to Alamar's global success," stated Luigi Pirovano, Managing Director, Alamar Biosciences Europe, srl. "Our logistical expertise, strategic location, and extensive experience in the life sciences sector will further enhance the entire customer experience with Alamar's products and services."

The opening of the European headquarters and distribution center marks a significant step forward for Alamar Biosciences in its mission to revolutionize precision proteomics and improve global healthcare outcomes. With this expansion, the company is well-positioned to continue providing cutting-edge solutions to the scientific community across Europe.

---

Show All News | Report Violation